Calithera Biosciences (CALA)

5.13 +0.15 (3.01%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (6/5/18 *Est.)
- Conference (6/20/2018)

Latest Headlines

Calithera to Present at the Jefferies and JMP Securities Healthcare Conferences in June June 6, 2018 5:01 AM - Globe NewsWire Form 8-K Calithera Biosciences, For: May 31 June 5, 2018 4:04 PM - SEC Filing Form 4 Calithera Biosciences, For: May 31 Filed by: AGARWAL SUNIL June 4, 2018 4:16 PM - SEC Filing Form 4 Calithera Biosciences, For: May 31 Filed by: JONES SUZY June 4, 2018 4:13 PM - SEC Filing Form 4 Calithera Biosciences, For: May 31 Filed by: PAKIANATHAN DEEPIKA June 4, 2018 4:10 PM - SEC Filing Form 4 Calithera Biosciences, For: May 31 Filed by: George Jean June 4, 2018 4:07 PM - SEC Filing Form 4 Calithera Biosciences, For: May 31 Filed by: DRACHMAN JONATHAN G June 4, 2018 4:07 PM - SEC Filing Form 4 Calithera Biosciences, For: May 31 Filed by: Wolff Henry Ward June 4, 2018 4:06 PM - SEC Filing Form 4 Calithera Biosciences, For: May 31 Filed by: Wise Blake June 4, 2018 4:06 PM - SEC Filing Results from Phase 1 Study of CB-839 in Combination with Capecitabine in Advanced Solid Tumors to be Presented at the 2018 American Society of Clinical Oncology (ASCO) June 4, 2018 8:01 AM - Globe NewsWire Research Report Identifies Monster Beverage, Infinera, Zynga, Calithera Biosciences, Marathon Oil, and National Instruments with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement May 16, 2018 7:30 AM - Globe NewsWire Viking Global's 13F Shows New Stakes in Alibaba (BABA), BioMarin (BMRN) and Western Digital (WDC), Increase in Microsoft (MSFT), Wells Fargo (WFC) (More...) May 15, 2018 12:08 PM - StreetInsider Form CT ORDER Calithera Biosciences, May 10, 2018 5:38 PM - SEC Filing Form 10-Q Calithera Biosciences, For: Mar 31 May 10, 2018 4:49 PM - SEC Filing Form 8-K Calithera Biosciences, For: May 10 May 10, 2018 4:24 PM - SEC Filing Calithera Biosciences Reports First Quarter 2018 Financial Results and Recent Highlights May 10, 2018 4:05 PM - Globe NewsWire Form CT ORDER Calithera Biosciences, May 1, 2018 9:45 AM - SEC Filing Calithera Biosciences Announces CB-839 Abstracts Accepted for Presentation at ASCO 2018 April 25, 2018 4:03 PM - Globe NewsWire Pre-Open Movers 04/18: (NBEV) (TLGT) (TXT) (EBAY) Higher; (AGLE) (CATB) (LRCX) (IBM) Lower (more...) April 18, 2018 9:06 AM - StreetInsider Calithera Biosciences (CALA) Granted FDA Fast Track Designation for CB-839 in Combination with Cabozantinib for Treatment of Patients with Advanced RCC April 18, 2018 7:03 AM - StreetInsider Calithera Biosciences Announces FDA Fast Track Designation Granted to CB-839 in Combination with Cabozantinib for Treatment of Patients with Advanced Renal Cell Carcinoma April 18, 2018 7:01 AM - Globe NewsWire Calithera Biosciences to Present New Preclinical Data for CB-839 at AACR Annual Meeting 2018 April 13, 2018 8:02 AM - Globe NewsWire Form DEFA14A Calithera Biosciences, April 10, 2018 5:06 PM - SEC Filing Form DEF 14A Calithera Biosciences, For: May 31 April 10, 2018 5:01 PM - SEC Filing Calithera Biosciences (CALA) PT Lowered to $12 at JMP Securities April 9, 2018 1:49 AM - StreetInsider UPDATE: Calithera Biosciences (CALA) PT Lowered to $12 at Leerink Citing ECHO-301 Data Disappointment April 6, 2018 9:16 AM - StreetInsider Form 4 Calithera Biosciences, For: Apr 03 Filed by: Sjogren Eric April 5, 2018 4:07 PM - SEC Filing Calithera to Present at Needham & Company 17th Annual Healthcare Conference March 23, 2018 8:00 AM - Globe NewsWire Full Article List